3M to invest nearly $150 million on expanding biopharma filtration capabilities
The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing facilities in Europe.
The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing facilities in Europe.
Acquisition will further strengthen Lonza’s bioconjugates offering through the integration of the industry-leading proprietary Synaffix technology platform and R&D capabilities, including payload and site-specific linker technology
One thousand times more soluble than L-cystine at neutral pH
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness
With over 150 leading companies, 300+ topline brands and knowledge-led conference sessions, the event is set to make a grand return to the South
Pharmaceutical sales was flat and stood at Rs. 309 crore as compared to Rs. 308 crore in Q4 FY22
The PP-based top and bottom webs are manufactured in a unique coextrusion process
Medical Device Policy is a progressive step in propelling the country towards Atmanirbharta in the heavily import dependent Medical Device Sector
Dr. Mandaviya urged the stakeholders to capitalize on the current opportunities
Subscribe To Our Newsletter & Stay Updated